Waldschmidt, D., Teufel, M., Koechert, K., Meinhardt, G. and Bruix, J. (2018). Efficacy of regorafenib (REG) in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial according to alpha-fetoprotein (AFP) and c-Met levels as predictors of poor prognosis. Oncol. Res. Treat., 41. S. 281 - 283. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Waldschmidt, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Teufel, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koechert, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Meinhardt, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bruix, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-201757
Journal or Publication Title: Oncol. Res. Treat.
Volume: 41
Page Range: S. 281 - 283
Date: 2018
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/20175

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item